Psychological and cognitive effects of long-term peyote use among Native Americans.
John H Halpern, Andrea R Sherwood, James I Hudson, Deborah Yurgelun-Todd, Harrison G Pope
Biological psychiatry October 15, 2005 DOI: 10.1016/j.biopsych.2005.06.038 via PubMed
Summary
AI-generated from the abstractRegular use of peyote, a hallucinogen-containing cactus, in a religious setting among Navajo Native Americans does not appear to cause long-term psychological or cognitive deficits. In a study comparing three groups—61 Native American Church members who regularly ingested peyote, 36 individuals with past alcohol dependence who had been sober for at least two months, and 79 individuals with minimal substance use—the peyote group showed no significant differences on a mental health inventory or ten neuropsychological tests compared to the minimal-use group. In contrast, the former alcoholic group showed significant deficits on all mental health scales and two neuropsychological measures. Total lifetime peyote use was not linked to worse performance. These findings may not apply to illicit hallucinogen users.
Study at a glance
| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 176 |
| Population | Navajo Native Americans aged 18-45 |
| Citations | 186 |
| Key finding | Regular peyote use in a religious setting was not associated with psychological or cognitive deficits, while past alcohol dependence was. |
Abstract
Hallucinogens are widely used, both by drug abusers and by peoples of traditional cultures who ingest these substances for religious or healing purposes. However, the long-term residual psychological and cognitive effects of hallucinogens remain poorly understood. We recruited three groups of Navajo Native Americans, age 18-45: 1) 61 Native American Church members who regularly ingested peyote, a hallucinogen-containing cactus; 2) 36 individuals with past alcohol dependence, but currently sober at least 2 months; and 3) 79 individuals reporting minimal use of peyote, alcohol, or other substances. We administered a screening interview, the Rand Mental Health Inventory (RMHI), and ten standard neuropsychological tests of memory and attentional/executive functions. Compared to Navajos with minimal substance use, the peyote group showed no significant deficits on the RMHI or any neuropsychological measures, whereas the former alcoholic group showed significant deficits (p < .05) on every scale of the RMHI and on two neuropsychological measures. Within the peyote group, total lifetime peyote use was not significantly associated with neuropsychological performance. We found no evidence of psychological or cognitive deficits among Native Americans using peyote regularly in a religious setting. It should be recognized, however, that these findings may not generalize to illicit hallucinogen users.